Tempus AI (NASDAQ:TEM) & PubMatic (NASDAQ:PUBM) Head-To-Head Analysis

Tempus AI (NASDAQ:TEM) and PubMatic (NASDAQ:PUBM) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, institutional ownership, valuation, earnings, analyst recommendations, dividends and profitability.

Insider & Institutional Ownership

64.3% of PubMatic shares are held by institutional investors. 2.9% of PubMatic shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Profitability

This table compares Tempus AI and PubMatic’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Tempus AI	N/A	N/A	N/A
PubMatic	7.08%	6.92%	3.07%

Earnings and Valuation

This table compares Tempus AI and PubMatic”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tempus AI	$595.57 million	13.67	N/A	N/A	N/A
PubMatic	$282.25 million	2.58	$8.88 million	$0.21	69.43

PubMatic has lower revenue, but higher earnings than Tempus AI.

Analyst Ratings

This is a breakdown of recent ratings and target prices for Tempus AI and PubMatic, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tempus AI	0	1	9	0	2.90
PubMatic	0	3	4	0	2.57

Tempus AI presently has a consensus target price of $45.56, suggesting a potential downside of 7.74%. PubMatic has a consensus target price of $21.00, suggesting a potential upside of 44.03%. Given PubMatic’s higher probable upside, analysts plainly believe PubMatic is more favorable than Tempus AI.

Summary

PubMatic beats Tempus AI on 6 of the 10 factors compared between the two stocks.

About Tempus AI

Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO.

About PubMatic

PubMatic, Inc., a technology company, engages in the provision of a cloud infrastructure platform that enables real-time programmatic advertising transactions for digital content creators, advertisers, agencies, agency trading desks, and demand side platforms worldwide. Its PubMatic SSP, a sell-side platform, used for the purchase and sale of digital advertising inventory for publishers and buyers. The company also provides solutions, including OpenWrap, a header bidding solution; Openwrap OTT, a prebid-powered unified bidding solution; Openwrap SDK, an enterprise-grade management tools and analytics; Connect, a solution that provides additional data and insights to publishers and buyers; Activate, which allows buyers to execute direct deals on its platform across publisher inventory; Convert, a commerce media solution; and Identity Hub, an ID management tool for publishers that leverages specialized technology?infrastructure?to simplify the complex alternative identifier marketplace. Its platform supports an array of ad formats and digital device types, including mobile app, mobile web, desktop, display, video, over-the-top (OTT), connected television, and media. The company was incorporated in 2006 and is based in Redwood City, California.